Information Provided By:
Fly News Breaks for March 29, 2018
DXCM
Mar 29, 2018 | 14:39 EDT
Piper Jaffray analyst JP McKim said, after digging deeper into the special controls data, that Dexcom made a "savvy move" creating a "faster way and reduced burden to market for their pipeline projects while [competitors] will most likely have to go through the class III pathway." McKim said he remains a buyer of Dexcom shares, and kept an Overweight rating on the company.
News For DXCM From the Last 2 Days
DXCM
Apr 25, 2024 | 15:11 EDT
Pre-earnings options volume in DexCom is 11.4x normal with calls leading puts 11:2. Implied volatility suggests the market is anticipating a move near 5.8%, or $8.05, after results are released. Median move over the past eight quarters is 5.4%.